Leukemia

Adolescents and young adults with overweight or obesity had poorer clinical outcomes than their normal-weight counterparts after receiving a pediatric regimen for treatment of acute lymphoblastic leukemia, study results showed.

Overall incidence of pediatric cancer in the United States increased 0.5% annually on average between 2003 and 2019, according to a CDC study published in Journal of the National Cancer Institute.

In his new role as president and CEO of The Leukemia & Lymphoma Society, pediatric hematologist oncologist E. Anders Kolb, MD, aims to expand his life’s work in advancing blood cancer research and therapies for patients of all ages.

Researchers at Tisch Cancer Center have created innovative models of acute myeloid leukemia, offering an unprecedented resource for studying this deadly blood cancer, according to a study published in Blood Cancer Discovery.

In this video, Eunice Wang, MD, discussed a retrospective analysis looking at outcomes of chimeric antigen receptor T-cell therapy for patients diagnosed with B-cell acute lymphoblastic leukemia, presented at ASCO Annual Meeting.

In this video, Eunice Wang, MD, discussed an abstract relating to new chimeric antigen receptor T-cell therapies treating acute lymphocytic leukemia, presented at ASCO Annual Meeting.

CHICAGO — Lisocabtagene maraleucel significantly improved complete remission rates among adults with relapsed or refractory chronic lymphocytic leukemia, results from the pivotal phase 2 TRANSCEND CLL 004 trial showed.

CHICAGO — Fewer than half of adolescents and young adults with acute lymphoblastic leukemia received first-line treatment at a specialized cancer center, despite an association of such treatment with longer survival, study results showed.

A partnership between health care systems along the U.S.-Mexico border led to clinically meaningful improvement in survival outcomes among children with acute lymphoblastic leukemia, study results showed.